Yu Xiangyang, Wen Yingsheng, Qin Rongqing, Lin Yongbin, Zhang Xuewen, Wang Weidong, Chen Yongqiang, Zhang Lanjun
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
Thorac Cancer. 2018 Mar;9(3):360-367. doi: 10.1111/1759-7714.12586. Epub 2018 Jan 12.
Primary pulmonary lymphoepithelioma-like carcinoma is a rare subtype of lung cancer. Until now, the characteristics of lymph nodes metastases in resectable cases have not yet been reported.
In this study, a total of 87 consecutive patients with primary pulmonary lymphoepithelioma-like carcinoma that received surgical treatment were investigated from October 1999 to August 2016. The clinical and radiological data and follow-up information were extracted from hospital records in detail.
In a univariate analysis, those patients with an early pathological stage (I-II), low rate of lymph node metastases (<30%) and a low number of positive lymph nodes (<5) showed longer recurrence-free survival and overall survival (all P < 0.05). However, the early pathological stage was identified as the only factor independently associated with recurrence-free survival by multivariate analysis (P = 0.038). In a preoperative lymph nodes evaluation, the accuracy and specificity of computed tomography alone were 52.9% (46/87) and 88% (302/343), respectively, and 73.2% of these cases with incorrect nodal staging (30/41) were upstaged. Skipping metastases were more frequent in operated stage N2 cases (71.4%), whereas whether or not those patients showed skipping metastasis did not affect their recurrence-free survival or overall survival (P > 0.05). The highest metastasis frequencies for specific lobes with primary lymphoepithelioma-like carcinoma are as follows: #5 left upper lobe (21.4%); #7 left lower lobe (40.7%); #2R (28.6%) and/or #4R (14.3%) right upper lobe; #7 (42.9%) right lower lobe; #7 (28%) and/or superior mediastinal nodes (36%) right middle lobe.
Based on accurate staging and uncertain survival benefit, complete mediastinal lymph nodes dissection is still required for curative resection.
原发性肺淋巴上皮瘤样癌是肺癌的一种罕见亚型。迄今为止,可切除病例的淋巴结转移特征尚未见报道。
本研究对1999年10月至2016年8月期间连续接受手术治疗的87例原发性肺淋巴上皮瘤样癌患者进行了调查。详细提取了医院记录中的临床、放射学数据及随访信息。
单因素分析显示,病理分期较早(I-II期)、淋巴结转移率较低(<30%)及阳性淋巴结数量较少(<5个)的患者无复发生存期和总生存期较长(均P<0.05)。然而,多因素分析确定早期病理分期是与无复发生存期独立相关的唯一因素(P=0.038)。在术前淋巴结评估中,单纯计算机断层扫描的准确性和特异性分别为52.9%(46/87)和88%(302/343),其中73.2%的病例分期错误(30/41)为分期上调。跳跃性转移在手术分期为N2的病例中更为常见(71.4%),而这些患者是否出现跳跃性转移并不影响其无复发生存期或总生存期(P>0.05)。原发性肺淋巴上皮瘤样癌特定肺叶的最高转移频率如下:左肺上叶#5(21.4%);左肺下叶#7(40.7%);右肺上叶#2R(28.6%)和/或#4R(14.3%);右肺下叶#7(42.9%);右肺中叶#7(28%)和/或上纵隔淋巴结(36%)。
基于准确分期及生存获益不确定,根治性切除仍需行完整的纵隔淋巴结清扫。